NAN vs PEB

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

46LOW

PEB

PACIFIC ED FPO NZX [PEB]

46LOW

Score Breakdown

NAN PEB
Technical
61
58
Catalyst
50
48
Sentiment
50
50
Fundamental
87
36
Momentum
41
67
Risk Gate
40
37

Key Metrics

NAN Metric PEB
$1.1BMarket Cap$158.5M
1.1MAvg Volume (20d)21K
+11.7%Short Interest+0.1%
$5.08052-Week High$0.220
$3.21052-Week Low$0.070
+3.0%Daily Change-3.1%
$3.615Entry Price$0.155
+10.1%ROE-102.3%
+9.9%Profit Margin-189.4%

Active Signals

NAN Signals

●MACD momentum is picking up steam
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.3x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

PEB Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.0x normal while price falls — heavy selling pressure
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (3 quarters) - dilution risk
●Moderate P/S ratio (8.7x)
●Revenue in sharp decline (-40%)

Ask Scout AI to compare NAN and PEB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NAN Full Analysis → PEB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).